Combined phacoemulsification and deep sclerectomy (PDS) with intraoperative mitomycin C (MMC) augmentation

Eye

Volumn 22, Issue 8, 2008, Pages 1040-1049

  Anand, S ^a   Anand, N ^b  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^b HUDDERSFIELD ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIGLAUCOMA AGENT; BETAMETHASONE; FLUOROURACIL; MITOMYCIN C; STEROID;

AGE; AGED; ARTICLE; CASE STUDY; CATARACT; CONTROLLED STUDY; FEMALE; FOLLOW UP; GLAUCOMA; HUMAN; INTERMETHOD COMPARISON; INTRAOCULAR HYPOTENSION; INTRAOCULAR PRESSURE; IRIDOTOMY; LENS IMPLANT; MAJOR CLINICAL STUDY; MALE; NEODYMIUM LASER; PATIENT SAFETY; PEROPERATIVE CARE; PHACOEMULSIFICATION; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; POSTOPERATIVE INFLAMMATION; POSTOPERATIVE PERIOD; PROBABILITY; SCLERECTOMY; TRABECULECTOMY; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 50449106938     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/sj.eye.6702833     Document Type: Article

References (32)

1. Ambresin A, Shaarawy T, Mermoud A. Deep sclerectomy with collagen implant in one eye compared with trabeculectomy in the other eye of the same patient. J Glaucoma 2002; 11: 214-220.
2. Mermoud A, Schnyder CC. Nonpenetrating filtering surgery in glaucoma. Curr Opin Ophthalmol 2000; 11: 151-157.
3. Cillino S, Pace FD, Casuccio A, Calvaruso L, Morreale D, Vadala M et al. Deep sclerectomy vs punch trabeculectomy with or without phacoemulsification: A randomized clinical trial. J Glaucoma 2004; 13: 500-506.
4. El Sayyad F, Helal M, El Kholify H, Khalil M, El Maghraby A. Nonpenetrating deep sclerectomy vs trabeculectomy in bilateral primary open-angle glaucoma. Ophthalmology 2000; 107: 1671-1674.
5. Friedman DS, Jampel HD, Lubomski LH, Kempen JH, Quigley H, Congdon N et al. Surgical strategies for coexisting glaucoma and cataract: An evidence-based update. Ophthalmology 2002; 109: 1902-1913.
6. Gianoli F, Schnyder CC, Bovey E, Mermoud A. Combined surgery for cataract and glaucoma: Phacoemulsification and deep sclerectomy compared with phacoemulsification and trabeculectomy. J Cataract Refract Surg 1999; 25: 340-346.
7. Bindlish R, Condon GP, Schlosser JD, D'Antonio J, Lauer KB, Lehrer R. Efficacy and safety of mitomycin-C in primary trabeculectomy: Five-year follow-up. Ophthalmology 2002; 109: 1336-1341.
8. DeBry PW, Perkins TW, Heatley G, Kaufman P, Brumback LC. Incidence of late-onset bleb-related complications following trabeculectomy with mitomycin. Arch Ophthalmol 2002; 120: 297-300.
9. Funnell CL, Clowes M, Anand N. Combined cataract and glaucoma surgery with mitomycin C: Phacoemulsification-trabeculectomy compared to phacoemulsification-deep sclerectomy. Br J Ophthalmol 2005; 89 694-698.
10. Wells AP, Cordeiro MF, Bunce C, Khaw PT. Cystic bleb formation and related complications in limbus- vs fornix-based conjunctival flaps in pediatric and young adult trabeculectomy with mitomycin C. Ophthalmology 2003; 110: 2192-2197.
11. Shin DH, Tsai CS, Kupin TH, Olivier MM. Retained cellulose sponge after trabeculectomy with adjunctive subconjunctival mitomycin C. Am J Ophthalmol 1994; 118: 111-112.
12. Poole TRG, Gillespie IH, Knee G, Whitworth J. Microscopic fragmentation of ophthalmic surgical sponge spears used for delivery of antiproliferative agents in glaucoma filtering surgery. Br J Ophthalmol 2002; 86: 1448-1449.
13. Matsuo H, Tomidokoro A, Suzuki Y, Shirato S, Araie M. Late-onset transconjunctival oozing and point leak of aqueous humor from filtering bleb after trabeculectomy. Am J Ophthalmol 2002; 133: 456-462.
14. Anand N, Arora S, Clowes M. Mitomycin C augmented glaucoma surgery: evolution of filtering bleb avascularity, transconjunctival oozing, and leaks. Br J Ophthalmol 2006; 90: 175-180.
15. Anand N, Atherley C. Deep sclerectomy augmented with mitomycin C. Eye 2005; 19: 442-450.
16. The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. The AGIS investigators. Am J Ophthalmol 2000; 130: 429-440.
17. Collaborative Normal-Tension Glaucoma Study Group. The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Am J Ophthalmol 1998; 126: 498-505.
18. Mermoud A, Karlen ME, Schnyder CC, Sickenberg M, Chiou AG, Hediguer SE et al. Nd:YAg goniopuncture after deep sclerectomy with collagen implant. Ophthalmic Surg Lasers 1999; 30: 120-125.
19. Lachkar Y, Neverauskiene J, Jeanteur-Lunel MN, Gracies H, Berkani M, Ecoffet M et al. Nonpenetrating deep sclerectomy: A 6-year retrospective study. Eur J Ophthalmol 2004; 14: 26-36.
20. Hyams M, Geyer O. Iris prolapse at the surgical site: A late complication of nonpenetrating deep sclerectomy. Ophthalmic Surg Lasers Imaging 2003; 34: 132-135.
21. Kim CY, Hong YJ, Seong GJ, Koh HJ, Kim SS. Iris synechia after laser goniopuncture in a patient having deep sclerectomy with a collagen implant. J Cataract Refract Surg 2002; 28: 900-902.
22. Vuori ML. Complications of Neodymium: YAG laser goniopuncture after deep sclerectomy. Acta Ophthalmol Scand 2003; 81: 573-576.
23. Vuori ML. Gonioscopic view of the trabeculo-Descemet's membrane after deep sclerectomy. Acta Ophthalmol Scand 2004; 82: 154-157.
24. Wilkins M, Indar A, Wormald R. Intra-operative mitomycin C for glaucoma surgery. Cochrane Database Syst Rev 2005; CD002897.
25. Kozobolis VP, Christodoulakis EV, Tzanakis N, Zacharopoulos I, Pallikaris IG. Primary deep sclerectomy vs primary deep sclerectomy with the use of mitomycin C in primary open-angle glaucoma. J Glaucoma 2002; 11: 287-293.
26. Neudorfer M, Sadetzki S, Anisimova S, Geyer O. Nonpenetrating deep sclerectomy with the use of adjunctive mitomycin C. Ophthalmic Surg Lasers Imaging 2004; 35: 6-12.
27. Cillino S, Di PF, Casuccio A, Lodato G. Deep sclerectomy vs punch trabeculectomy: Effect of low-dosage mitomycin C. Ophthalmologica 2005; 219: 281-286.
28. Jampel HD, Friedman DS, Lubomski LH, Kempen JH, Quigley H, Congdon N et al. Effect of technique on intraocular pressure after combined cataract and glaucoma surgery: An evidence-based review. Ophthalmology 2002; 109: 2215-2224.
29. Cohen JS, Greff LJ, Novack GD, Wind BE. A placebo-controlled, double-masked evaluation of mitomycin C in combined glaucoma and cataract procedures. Ophthalmology 1996; 103: 1934-1942.
30. Shin DH, Kim YY, Sheth N, Ren J, Shah M, Kim C et al. The role of adjunctive mitomycin C in secondary glaucoma triple procedure as compared to primary glaucoma triple procedure. Ophthalmology 1998; 105: 740-745.
31. Shin DH, Ren J, Juzych MS, Hughes BA, Kim C, Song MS et al. Primary glaucoma triple procedure in patients with primary open-angle glaucoma: The effect of mitomycin C in patients with and without prognostic factors for filtration failure. Am J Ophthalmol 1998; 125: 346-352.
32. Hu CY, Matsuo H, Tomita G, Suzuki Y, Araie M, Shirato S, Tanaka S. Clinical characteristics and leakage functioning blebs after trabeculectomy with mitomycin-C in primary glaucoma patients. Ophthalmology 2003; 110: 345-352.